Cargando…
Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study
OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) increase the risk of HIV transmission among men who have sex with men (MSM). Diagnosis of NG/CT may provide an efficient entry point for prevention of HIV through the delivery of pre-exposure prophylaxis (PrEP); however, the addit...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429744/ https://www.ncbi.nlm.nih.gov/pubmed/30837248 http://dx.doi.org/10.1136/bmjopen-2018-023453 |
_version_ | 1783405653982707712 |
---|---|
author | Kasaie, Parastu Schumacher, Christina M Jennings, Jacky M Berry, Stephen A Tuddenham, Susan A Shah, Maunank S Rosenberg, Eli S Hoover, Karen W Gift, Thomas L Chesson, Harrell German, Danielle Dowdy, David W |
author_facet | Kasaie, Parastu Schumacher, Christina M Jennings, Jacky M Berry, Stephen A Tuddenham, Susan A Shah, Maunank S Rosenberg, Eli S Hoover, Karen W Gift, Thomas L Chesson, Harrell German, Danielle Dowdy, David W |
author_sort | Kasaie, Parastu |
collection | PubMed |
description | OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) increase the risk of HIV transmission among men who have sex with men (MSM). Diagnosis of NG/CT may provide an efficient entry point for prevention of HIV through the delivery of pre-exposure prophylaxis (PrEP); however, the additional population-level impact of targeting PrEP to MSM diagnosed with NG/CT is unknown. DESIGN: An agent-based simulation model of NG/CT and HIV cocirculation among MSM calibrated against census data, disease surveillance reports and the US National HIV Behavioral Surveillance study. SETTING: Baltimore City, Maryland, USA. INTERVENTIONS: PrEP implementation was modelled under three alternative scenarios: (1) PrEP delivery at NG/CT diagnosis (targeted delivery), (2) PrEP evaluation at NG/CT screening/testing and (3) PrEP evaluation in the general community (untargeted). MAIN OUTCOME: The projected incidence of HIV after 20 years of PrEP delivery under two alternatives: when equal numbers of MSM are (1) screened for PrEP or (2) receive PrEP in each year. RESULTS: Assuming 60% uptake and 60% adherence, targeting PrEP to MSM diagnosed with NG/CT could reduce HIV incidence among MSM in Baltimore City by 12.4% (95% uncertainty range (UR) 10.3% to 14.4%) in 20 years, relative to no PrEP. Expanding the coverage of NG/CT screening (such that individuals experience a 50% annual probability of NG/CT screening and evaluation for PrEP on NG/CT diagnosis) can further increase the impact of targeted PrEP to generate a 22.0% (95% UR 20.1% to 23.9%) reduction in HIV incidence within 20 years. When compared with alternative implementation scenarios, PrEP evaluation at NG/CT diagnosis increased impact of PrEP on HIV incidence by 1.5(95% UR 1.1 to 1.9) times relative to a scenario in which PrEP evaluation happened at the time of NG/CT screening/testing and by 1.6 (95% UR 1.2 to 2.2) times relative to evaluating random MSM from the community. CONCLUSIONS: Targeting MSM infected with NG/CT increases the efficiency and effectiveness of PrEP delivery. If high levels of sexually transmitted infection screening can be achieved at the community level, NG/CT diagnosis may be a highly effective entry point for PrEP initialisation. |
format | Online Article Text |
id | pubmed-6429744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-64297442019-04-05 Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study Kasaie, Parastu Schumacher, Christina M Jennings, Jacky M Berry, Stephen A Tuddenham, Susan A Shah, Maunank S Rosenberg, Eli S Hoover, Karen W Gift, Thomas L Chesson, Harrell German, Danielle Dowdy, David W BMJ Open Epidemiology OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) increase the risk of HIV transmission among men who have sex with men (MSM). Diagnosis of NG/CT may provide an efficient entry point for prevention of HIV through the delivery of pre-exposure prophylaxis (PrEP); however, the additional population-level impact of targeting PrEP to MSM diagnosed with NG/CT is unknown. DESIGN: An agent-based simulation model of NG/CT and HIV cocirculation among MSM calibrated against census data, disease surveillance reports and the US National HIV Behavioral Surveillance study. SETTING: Baltimore City, Maryland, USA. INTERVENTIONS: PrEP implementation was modelled under three alternative scenarios: (1) PrEP delivery at NG/CT diagnosis (targeted delivery), (2) PrEP evaluation at NG/CT screening/testing and (3) PrEP evaluation in the general community (untargeted). MAIN OUTCOME: The projected incidence of HIV after 20 years of PrEP delivery under two alternatives: when equal numbers of MSM are (1) screened for PrEP or (2) receive PrEP in each year. RESULTS: Assuming 60% uptake and 60% adherence, targeting PrEP to MSM diagnosed with NG/CT could reduce HIV incidence among MSM in Baltimore City by 12.4% (95% uncertainty range (UR) 10.3% to 14.4%) in 20 years, relative to no PrEP. Expanding the coverage of NG/CT screening (such that individuals experience a 50% annual probability of NG/CT screening and evaluation for PrEP on NG/CT diagnosis) can further increase the impact of targeted PrEP to generate a 22.0% (95% UR 20.1% to 23.9%) reduction in HIV incidence within 20 years. When compared with alternative implementation scenarios, PrEP evaluation at NG/CT diagnosis increased impact of PrEP on HIV incidence by 1.5(95% UR 1.1 to 1.9) times relative to a scenario in which PrEP evaluation happened at the time of NG/CT screening/testing and by 1.6 (95% UR 1.2 to 2.2) times relative to evaluating random MSM from the community. CONCLUSIONS: Targeting MSM infected with NG/CT increases the efficiency and effectiveness of PrEP delivery. If high levels of sexually transmitted infection screening can be achieved at the community level, NG/CT diagnosis may be a highly effective entry point for PrEP initialisation. BMJ Publishing Group 2019-03-04 /pmc/articles/PMC6429744/ /pubmed/30837248 http://dx.doi.org/10.1136/bmjopen-2018-023453 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Epidemiology Kasaie, Parastu Schumacher, Christina M Jennings, Jacky M Berry, Stephen A Tuddenham, Susan A Shah, Maunank S Rosenberg, Eli S Hoover, Karen W Gift, Thomas L Chesson, Harrell German, Danielle Dowdy, David W Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study |
title | Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study |
title_full | Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study |
title_fullStr | Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study |
title_full_unstemmed | Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study |
title_short | Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study |
title_sort | gonorrhoea and chlamydia diagnosis as an entry point for hiv pre-exposure prophylaxis: a modelling study |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429744/ https://www.ncbi.nlm.nih.gov/pubmed/30837248 http://dx.doi.org/10.1136/bmjopen-2018-023453 |
work_keys_str_mv | AT kasaieparastu gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT schumacherchristinam gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT jenningsjackym gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT berrystephena gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT tuddenhamsusana gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT shahmaunanks gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT rosenbergelis gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT hooverkarenw gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT giftthomasl gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT chessonharrell gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT germandanielle gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy AT dowdydavidw gonorrhoeaandchlamydiadiagnosisasanentrypointforhivpreexposureprophylaxisamodellingstudy |